Skip to main content


Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 3/2020

Ausgabe 3/2020

Inhaltsverzeichnis ( 26 Artikel )

21.07.2020 | Review | Ausgabe 3/2020

Optimism and coping: do they influence health outcomes in women with breast cancer? A systemic review and meta-analysis

Julie Fasano, Theresa Shao, Hsin-hui Huang, Alaina J. Kessler, Olivia P. Kolodka, Charles L. Shapiro

24.07.2020 | Review | Ausgabe 3/2020

The histopathological and molecular features of breast carcinoma with tumour budding—a systematic review and meta-analysis

Angus J. Lloyd, Éanna J. Ryan, Michael R. Boland, Sami Abd Elwahab, Carmel Malone, Karl J. Sweeney, Kevin M. Barry, Raymond McLaughlin, Michael J. Kerin, Aoife J. Lowery

25.07.2020 | COVID-19 | Review | Ausgabe 3/2020 Zur Zeit gratis

A system for risk stratification and prioritization of breast cancer surgeries delayed by the COVID-19 pandemic: preparing for re-entry

Barbara L. Smith, Anvy Nguyen, Jenna E. Korotkin, Bridget N. Kelly, Michelle C. Specht, Laura M. Spring, Beverly Moy, Steven J. Isakoff, Michele A. Gadd

20.07.2020 | Preclinical study | Ausgabe 3/2020

Differential expression and prognostic relevance of autophagy-related markers ATG4B, GABARAP, and LC3B in breast cancer

Svetlana Bortnik, Basile Tessier-Cloutier, Samuel Leung, Jing Xu, Karama Asleh, Samantha Burugu, Jamie Magrill, Kendall Greening, Fatemeh Derakhshan, Stephen Yip, Tony Ng, Karen A. Gelmon, Torsten O. Nielsen, Sharon M. Gorski

21.07.2020 | Preclinical study | Ausgabe 3/2020

Lysine oxidase exposes a dependency on the thioredoxin antioxidant pathway in triple-negative breast cancer cells

Olga E. Chepikova, Dmitry Malin, Elena Strekalova, Elena V. Lukasheva, Andrey A. Zamyatnin Jr., Vincent L. Cryns

21.07.2020 | Preclinical study | Ausgabe 3/2020

Parity reduces mammary repopulating activity but does not affect mammary stem cells defined as CD24 + CD29/CD49fhi in mice

Genevieve V. Dall, Jessica Vieusseux, Yashar Seyed-Razavi, Nathan Godde, Mandy Ludford-Menting, Sarah M. Russell, Alan Ashworth, Robin L. Anderson, Gail P. Risbridger, Mark Shackleton, Kara L. Britt

23.07.2020 | Preclinical study | Ausgabe 3/2020

Patients with benign papilloma diagnosed on core biopsies and concordant pathology-radiology findings can be followed: experiences from multi-specialty high-risk breast lesion conferences in an academic center

Zhongliang Ma, Cletus A. Arciero, Toncred M. Styblo, Haibo Wang, Michael A. Cohen, Xiaoxian Li

24.07.2020 | Preclinical study | Ausgabe 3/2020 Open Access

Loss of progesterone receptor is associated with distinct tyrosine kinase profiles in breast cancer

Andliena Tahiri, Xavier Tekpli, Somisetty V. Satheesh, Rik DeWijn, Torben Lüders, Ida R. Bukholm, Antoni Hurtado, Jürgen Geisler, Vessela N. Kristensen

26.07.2020 | Preclinical study | Ausgabe 3/2020

Evaluation of PD-L1, tumor-infiltrating lymphocytes, and CD8+ and FOXP3+ immune cells in HER2-positive breast cancer treated with neoadjuvant therapies

Jing Zhao, Jane Meisel, Yi Guo, Rita Nahta, Kung Lin Hsieh, Limin Peng, Zhimin Wei, Ruth O’Regan, Xiaoxian Li

30.07.2020 | Preclinical study | Ausgabe 3/2020 Open Access

Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants

Waleed S. Al Amri, Diana E. Baxter, Andrew M. Hanby, Lucy F. Stead, Eldo T. Verghese, James L. Thorne, Thomas A. Hughes

22.07.2020 | Clinical trial | Ausgabe 3/2020

Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy

Arkadiusz Z. Dudek, Li C. Liu, James H. Fischer, Elizabeth L. Wiley, Jasgit C. Sachdev, Jonathan Bleeker, Randolph W. Hurley, Debra A. Tonetti, Gregory R. J. Thatcher, Robert P. Venuti, Ruth M. O’Regan MD

27.07.2020 | Clinical trial | Ausgabe 3/2020 Open Access

The development and initial evaluation of the Diarrhoea Management Diary (DMD) in patients with metastatic breast cancer

Helena Harder, Valerie M. Shilling, Shirley F. May, David Cella, Peter Schmid, Lesley J. Fallowfield

31.07.2020 | Clinical Trial | Ausgabe 3/2020

Pre-operative axillary ultrasound with fine-needle aspiration cytology performance and predictive factors of false negatives in axillary lymph node involvement in early breast cancer

Judicael Hotton, Julia Salleron, Philippe Henrot, Julie Buhler, Léa Leufflen, Philippe Rauch, Frederic Marchal

20.07.2020 | Epidemiology | Ausgabe 3/2020

Financial toxicity and contralateral prophylactic mastectomy: an analysis using propensity score methods

Malke Asaad, Stefanos Boukovalas, Carrie K. Chu, Yu-Li Lin, Cristina M. Checka, Mark W. Clemens, Rachel A. Greenup, Anaeze C. Offodile II

21.07.2020 | Epidemiology | Ausgabe 3/2020

Evaluating the impact of axillary dissection on recurrence-free survival by extent of nodal disease in invasive lobular carcinoma of the breast

Mary Kathryn Abel, Kelly Fahrner-Scott, Jasmine Wong, Michael Alvarado, Cheryl Ewing, Laura J. Esserman, Catherine Park, Rita A. Mukhtar

21.07.2020 | Epidemiology | Ausgabe 3/2020 Open Access

Sarcoma of the breast: breast cancer history as etiologic and prognostic factor—A population-based case–control study

Fredrik Karlsson, Fredrik Granath, Karin E. Smedby, Jan Zedenius, Robert Bränström, Inga-Lena Nilsson

21.07.2020 | Epidemiology | Ausgabe 3/2020

Radial scars and complex sclerosing lesions on core needle biopsy of the breast: upgrade rates and long-term outcomes

E. M. Quinn, E. Dunne, F. Flanagan, S. Mahon, M. Stokes, M. J. Barry, M. Kell, S. M. Walsh

21.07.2020 | Epidemiology | Ausgabe 3/2020

Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer

Ning Yi Yap, Nichole Yue Ting Tan, Chia Jie Tan, Kiley Wei-Jen Loh, Raymond Chee Hui Ng, Han Kiat Ho, Alexandre Chan

26.07.2020 | Epidemiology | Ausgabe 3/2020

Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer

Se Hyun Kim, Soomin Ahn, Koung Jin Suh, Yu Jung Kim, So Yeon Park, Eunyoung Kang, Eun-Kyu Kim, In Ah Kim, Sumin Chae, Murim Choi, Jee Hyun Kim

26.07.2020 | Epidemiology | Ausgabe 3/2020

Variation in the UGT2B17 genotype, exemestane metabolism and menopause-related toxicities in the CCTG MAP.3 trial

Vikki Ho, Romain Pasquet, Shaman Luo, Gang Chen, Paul Goss, Dongsheng Tu, Philip Lazarus, Harriet Richardson, on behalf of the MAP3 Investigators

26.07.2020 | Epidemiology | Ausgabe 3/2020

Comparisons of breast conserving therapy versus mastectomy in young and old women with early-stage breast cancer: long-term results using propensity score adjustment method

Lize Wang, Yingjian He, Jinfeng Li, Tianfeng Wang, Yuntao Xie, Zhaoqing Fan, Tao Ouyang

27.07.2020 | Epidemiology | Ausgabe 3/2020

The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) metastatic breast cancer

Sudpreeda Chainitikun, James P. Long, Ruben Rodriguez-Bautista, Toshiaki Iwase, Debu Tripathy, Takeo Fujii, Naoto T. Ueno

29.07.2020 | Epidemiology | Ausgabe 3/2020

Diagnostic workup of early-stage breast cancer: can we choose more wisely?

Rona Aks, Shira Peleg Hasson, Ayelet Sivan, Tal Kohen, Larisa Rivo, Rinat Yerushalmi, Bella Kaufman, Amir Sonnenblick, Ido Wolf

29.07.2020 | Epidemiology | Ausgabe 3/2020

The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115)

Daniela Dornelles Rosa, José Bines, Gustavo Werutsky, Carlos Henrique Barrios, Eduardo Cronemberger, Geraldo Silva Queiroz, Vladmir C. Cordeiro de Lima, Ruffo Freitas-Júnior, José d’Oliveira Couto, Karla Emerenciano, Heloísa Resende, Susane Crocamo, Tomás Reinert, Brigitte Van Eyil, Yeni Nerón, Vanessa Dybal, Nicolas Lazaretti, Rita de Cassia Costamilan, Diocésio Alves Pinto de Andrade, Clarissa Mathias, Giovana Zerwes Vacaro, Giuliano Borges, Alessandra Morelle, Maira Caleffi, Carlos Sampaio Filho, Max S. Mano, Facundo Zaffaroni, Rafaela Gomes de Jesus, Sergio Daniel Simon

30.07.2020 | Epidemiology | Ausgabe 3/2020 Open Access

Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study

Emma J. Groen, Jan Hudecek, Lennart Mulder, Maartje van Seijen, Mathilde M. Almekinders, Stoyan Alexov, Anikó Kovács, Ales Ryska, Zsuzsanna Varga, Francisco-Javier Andreu Navarro, Simonetta Bianchi, Willem Vreuls, Eva Balslev, Max V. Boot, Janina Kulka, Ewa Chmielik, Ellis Barbé, Mathilda J. de Rooij, Winand Vos, Andrea Farkas, Natalja E. Leeuwis-Fedorovich, Peter Regitnig, Pieter J. Westenend, Loes F. S. Kooreman, Cecily Quinn, Giuseppe Floris, Gábor Cserni, Paul J. van Diest, Esther H. Lips, Michael Schaapveld, Jelle Wesseling, Grand Challenge PRECISION consortium

23.07.2020 | Brief Report | Ausgabe 3/2020

Atypical lobular hyperplasia on core needle biopsy: contemporary results from a large community hospital breast program

Dean Lumley, Deidre Stokes, Pawel Karwowski, Bonnie Edsall, John Francfort, Bradley Cohen, Anthony Capizzi, Zhi-Wei Ma, Anne Green, Johnny Kao

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.